The bilirubin blood test market is projected to witness steady growth, reaching an estimated valuation of USD 1.29 billion in 2024, and expanding to USD 1.38 billion in 2025. By 2034, the market is anticipated to grow to approximately USD 2.46 billion, expanding at a compound annual growth rate (CAGR) of 6.67% from 2025 to 2034. This growth is primarily driven by the increasing prevalence of liver diseases, neonatal jaundice, and advancements in diagnostic technologies.
Key Drivers of Market Growth
The market’s expansion is driven by technological advancements in testing methods, such as point-of-care devices and non-invasive testing techniques. Additionally, there is a growing awareness of liver health and the importance of preventive healthcare, further contributing to the increased demand for bilirubin blood tests.
Market Overview and Key Trends
-
North America holds the dominant revenue share of approximately 40% in the global bilirubin blood test market in 2024, driven by a strong healthcare infrastructure and rising awareness of liver-related diseases.
-
The Asia-Pacific region is expected to experience the highest growth rate during the forecast period, fueled by improving healthcare access and rising incidences of neonatal jaundice.
-
By test type, the total bilirubin test segment captured the largest market share of 62%, with point-of-care bilirubin measurements expected to grow at the fastest rate due to increasing demand for quick, on-site diagnostic tools.
-
The liver disease diagnosis & monitoring application segment dominated the market, accounting for 51% of market share in 2024, reflecting the key role of bilirubin tests in liver disease detection.
Top Companies in the Bilirubin Blood Test Market
1. Roche Diagnostics
About: Roche Diagnostics is a global leader in healthcare solutions, particularly in the diagnostics segment. The company specializes in advanced diagnostic technologies, including tests for liver diseases.
Products: Roche’s bilirubin blood test systems provide accurate and timely results, widely used in clinical laboratories and point-of-care testing settings.
Market Cap: USD 229 billion (as of 2024).
2. Abbott Laboratories
About: Abbott Laboratories is a healthcare giant, known for its innovative medical devices, diagnostics, and nutritional products. The company has a strong presence in the global diagnostics market.
Products: Abbott offers a comprehensive range of bilirubin blood testing devices, including those for point-of-care testing, providing fast and reliable results.
Market Cap: USD 211 billion (as of 2024).
3. Siemens Healthineers
About: Siemens Healthineers is a leading global medical technology company, offering a wide range of diagnostic products and services. The company focuses on improving patient outcomes through precision diagnostics.
Products: Siemens provides advanced bilirubin testing equipment, including laboratory instruments and point-of-care testing solutions for accurate and efficient diagnosis.
Market Cap: USD 75 billion (as of 2024).
4. Beckman Coulter
About: Beckman Coulter, a subsidiary of Danaher Corporation, is a prominent provider of laboratory instruments and reagents, including diagnostic tools for liver function testing.
Products: Their bilirubin test systems are used globally in hospitals and laboratories to monitor liver health.
Market Cap: USD 227 billion (Danaher’s total market cap as of 2024).
5. Thermo Fisher Scientific Inc.
About: Thermo Fisher Scientific is a global leader in laboratory services, life sciences, and diagnostics. The company’s innovative technologies support research and clinical diagnostics.
Products: Thermo Fisher offers bilirubin blood tests with high accuracy, often used for both clinical applications and research.
Market Cap: USD 232 billion (as of 2024).
6. Radiometer Medical
About: Radiometer, a part of Danaher, specializes in high-quality diagnostic instruments and systems, particularly in point-of-care testing for critical care.
Products: Their bilirubin testing solutions provide rapid results for neonatal jaundice and liver function monitoring.
Market Cap: As a part of Danaher Corporation, their market cap is included under Danaher’s total valuation of USD 227 billion.
7. Philips Healthcare
About: Philips Healthcare is a leading global medical technology company that designs and manufactures innovative medical devices and diagnostic solutions.
Products: Philips offers advanced bilirubin testing solutions, with a focus on easy-to-use point-of-care devices.
Market Cap: USD 54 billion (as of 2024).
8. Drägerwerk AG & Co. KGaA
About: Drägerwerk is a leading international company that focuses on medical and safety technology. Their diagnostic systems are used in critical care environments.
Products: Dräger’s bilirubin blood testing devices help monitor neonatal jaundice and liver function in hospitals and clinics.
Market Cap: USD 5.2 billion (as of 2024).
9. Nova Biomedical
About: Nova Biomedical is an innovator in the medical device industry, offering diagnostic testing solutions for critical care and point-of-care applications.
Products: Nova’s bilirubin testing devices are known for their precision and ease of use, ideal for both clinical laboratories and in-home healthcare.
Market Cap: Private company (market cap not publicly available).
10. Bayer AG
About: Bayer AG is a multinational company that focuses on healthcare and agriculture, providing diagnostic products for various applications, including liver health.
Products: Bayer offers comprehensive diagnostic solutions for bilirubin testing, widely used in hospitals and healthcare centers.
Market Cap: USD 60 billion (as of 2024).
11. Arkray Inc.
About: Arkray is a global leader in diagnostic testing systems, providing innovative solutions for point-of-care testing and laboratory diagnostics.
Products: Arkray offers bilirubin test devices that are highly accurate and reliable for detecting liver diseases.
Market Cap: Private company (market cap not publicly available).
12. A&T Corporation
About: A&T Corporation specializes in diagnostic equipment and reagents, including bilirubin test systems for hospitals and clinics.
Products: A&T’s bilirubin testing products are known for their high performance and accuracy in clinical diagnostics.
Market Cap: Private company (market cap not publicly available).
13. Gesan Production Srl
About: Gesan Production Srl is an Italian company that develops high-quality diagnostic instruments and reagents.
Products: The company manufactures bilirubin testing devices that are used for both neonatal and adult liver disease monitoring.
Market Cap: Private company (market cap not publicly available).
14. Sekisui Diagnostics
About: Sekisui Diagnostics provides innovative diagnostic products and services, focusing on point-of-care and laboratory testing systems.
Products: Sekisui’s bilirubin test devices are highly regarded for their reliability and fast results.
Market Cap: Private company (market cap not publicly available).
15. Mindray Bio-Medical Electronics Co., Ltd.
About: Mindray is a leading global developer and manufacturer of medical devices and solutions, with a focus on diagnostics, imaging, and patient monitoring.
Products: Mindray’s bilirubin testing solutions are used globally for early detection of liver disease and neonatal jaundice.
Market Cap: USD 30 billion (as of 2024).
If you have any questions, please feel free to contact us at sales@towardshealthcare.com
FAQs
1. What is the bilirubin blood test used for?
The bilirubin blood test is primarily used to assess liver function, diagnose liver diseases, and monitor conditions such as neonatal jaundice.
2. Why is the demand for bilirubin blood tests increasing?
The rising incidence of liver diseases, neonatal jaundice, and increased public awareness of liver health are driving the demand for accurate bilirubin testing.
3. What factors are contributing to the growth of the bilirubin blood test market?
Technological advancements, such as point-of-care devices and non-invasive testing, are improving diagnostic efficiency and accessibility, contributing to market growth.
4. Which region is expected to grow the fastest in the bilirubin blood test market?
The Asia-Pacific region is expected to grow at the fastest CAGR during the forecast period due to improved healthcare access and rising incidences of liver-related conditions.
5. What are the key players in the bilirubin blood test market?
Some of the key players in the market include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Thermo Fisher Scientific, and Mindray Bio-Medical Electronics, among others.
Source : https://www.towardshealthcare.com/insights/bilirubin-blood-test-market-sizing
Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5848